Propr Introduces Propr Paste, Completing Its Clinically Inspired System for Gentle, Long-Term Oral Health
New York, NY, March 11, 2026 (GLOBE NEWSWIRE) -- Propr®, the fluoride…
Real-World Commercial Experience with Ryoncil Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
January 26, 2026 18:45 ET | Source: Mesoblast Limited NEW YORK, Jan.…
